Scientists, including one of Indian-origin, have identified parts of human proteins which thehuman proteins could be using to hijack host cell processes, an advance that may lead to the development of new drugs for treating COVID-19.
Scientists at the European Molecular Biology Laboratory (EMBL) have developed a new microfluidic device to facilitate fast and inexpensive testing of cancer drugs on tumour cells.
Sartorius has announced a partnership with EMBL, the European Molecular Biology Laboratory. EMBL is one of the Europe’s leading research institutions with global reach.